Press Releases
Sun Pharma Launches RIOMET ER Oral Suspension in the U.S.
Sun Pharmaceutical Industries Ltd. announced that one of its whollyowned subsidiaries has launched Riomet ER™ in the U.S. as an adjunct to diet and...
Articles
Trademarks in the medical sphere: Practice, examination and obstacles for registration in Russia, Ukraine and the CIS
Pharmaceutical industry in Russia, Ukraine and in other CIS countries can be considered one of the most complex industries with a view to the...
Press Releases
Dulaglutide Receives FDA Approval for Reducing MACE in Type 2 Diabetics
The U.S. FDA has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have...
Clinical Trials
IQVIA Launches Avacare Clinical Research Network to Increase Patients Clinical and Research Options
IQVIA™ (NYSE: IQV), a leader in human data science, announced the launch of Avacare Clinical Research Network™, a technology-based global site network that opens...
Clinical Trials
CytoDyn Receives IRB Approval to Initiate Phase 2 Basket Trial for 22 Solid Tumor Cancers
CytoDyn Inc , a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, reported that it...
Drug Research
Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis
Swiss pharma giant Novartis and non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) have signed a collaboration and license agreement to...
IT & Data Management
SwRIs virtual screening software Rhodium increases processing power for coronavirus research
Drug discovery software at Southwest Research Institute is expanding the capacity to virtually screen drug compounds for possible treatment of coronavirus and other infectious...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read